SkyCell

PharmaLifeScience News

...

Samsung builds digital health credentials with Xealth buy
Samsung builds digital health credentials with Xealth buyPhil.TaylorTue, 08/07/2025 - 08:31Bookmark thisPhil.TaylorTue, 08/07/2025 - 08:31Bookmark this
READ MORE
...

GSK acquires efimosfermin alfa from Boston Pharma for $2bn
GSK has concluded the acquisition of efimosfermin alfa, an investigational therapeutic for serious liver disease, from Boston Pharmaceuticals
READ MORE
...

Trump’s 200% tariff threat could send shockwaves through pharma supply chains
Despite the threat of a 200% tariff on pharma by President Trump, most pharma stocks remained stable.
READ MORE

Alembic Pharmaceuticals acquires UTILITY therapeutics

Merck nears $10bn deal for respiratory drugmaker Verona

HeartBeat.bio and biotx.ai partner to develop new drugs for heart failure

Ireland’s First BioBrillouin Microscope Arrives at Trinity College Dublin

Vanderbilt and Parse Biosciences Join Forces to Accelerate Measles Antibody Discovery

J&J eyes prostate cancer label expansion for Akeega

Summit climbs on rumour of $15bn AstraZeneca interest

Pulmonary arterial hypertension market to reach $9.35bn across 7MM by 2034

Immune Cell Engager Partnering & Investment Summit

US measles elimination status at risk as cases soar

Balancing innovation and implementation: Embracing agentic AI as a strategic enabler in healthcare

2nd ADC & Novel Conjugates Partnering & Investment Summit

2nd Autoimmunity & Inflammation Partnering & Investment Summit

US measles cases reach 33-year high with active outbreaks in 14 states

The UK’s Apollo-backed insurance juggernaut
Ellab